CINCINNATI, Dec. 1, 2025 — Omni Fiber, a leading provider of high-speed fiber optic Internet services in the Midwest, today announced the closing of $150 million in incremental debt financing from Stonepeak Credit and Oak Hill Advisors (OHA), alongside an incremental $50 million equity investment from Oak Hill Capital. Additionally, Omni Fiber has closed a $10 million working capital facility with Republic Bank & Trust Company.

Founded in 2022 by management and Oak Hill Capital, Omni Fiber has invested over $400 million in building an XGS-PON fiber network and is on track to reach approximately 340,000 locations by the end of the year. The incremental financing from Stonepeak Credit and OHA, which follows a previous $150 million in debt financing from Stonepeak Credit announced in July 2024, will fund Omni Fiber’s continued expansion into more communities throughout the Midwest and Texas.

Omni Fiber provided service to its first community in December 2022 and now serves residential and business customers in approximately 60 small and mid-size communities in Ohio, Pennsylvania, Michigan, and Texas. Construction is in progress in approximately 25 communities, and network design and engineering activities are ongoing in many others.

Omni Fiber’s founding CEO, Darrick Zucco said, “We are grateful that the additional funds will accelerate our rapid expansion to bring fiber-optic connectivity to those who have been previously underserved. We welcome our new funding partners OHA and Republic Bank.”

Scott Baker, Managing Partner at Oak Hill Capital, added, “We are proud of our strong operating performance driven by the Omni Fiber management team and very pleased with the company’s continued growth. The Oak Hill additional equity investment, together with the incremental financing from debt partners, underscores our belief in the Omni Fiber business model.”

Ryan Roberge, Senior Managing Director at Stonepeak, added, “We continue to be impressed with the Omni Fiber team’s execution of their business plan. We are excited to upsize our investment and continue supporting the team and the high-quality fiber network they are deploying for customers in the Midwest.”

Greg Leveto, Portfolio Manager and Partner at OHA, said, “Omni Fiber has demonstrated strong execution and a clear commitment to expanding high-quality fiber broadband access in underserved communities. We are pleased to partner with Stonepeak and Oak Hill Capital Partners to support the company’s next phase of growth.”

About Omni Fiber
Founded in 2022, Omni Fiber is backed by Oak Hill Capital, one of the largest investment firms in the telecommunications industry. Based in Ohio, Omni Fiber is led by a leadership team with 100+ years of combined industry experience and provides 100% fiber-optic broadband Internet, TV, and Phone services to residential and business customers in the United States. Omni Fiber offers symmetrical speeds of up to 10 Gbps, no hidden fees, no data caps, Premium Wi-Fi included, local customer service, and competitive pricing. For more information, please visit www.omnifiber.com.

About Oak Hill Capital
Oak Hill Capital is a thematic, middle-market private equity firm focused primarily on investing in resilient, defensive growth-oriented services businesses in North America. The firm takes a systematic approach to identifying and building enduring franchises aligned with high conviction themes in (i) digital infrastructure; (ii) financial services; and (iii) essential services. Headquartered in New York City, with offices in Menlo Park and Stamford, over its ~40-year history, Oak Hill has invested in over 110 companies and has raised over $24 billion of initial capital commitments and co-investments since inception. For more information, please visit www.oakhill.com.

About Stonepeak Credit
Stonepeak Credit is the credit investing arm of Stonepeak, a leading alternative investment firm specializing in infrastructure and real assets with approximately $80 billion of assets under management. Stonepeak Credit targets credit investments across the transportation and logistics, energy and energy transition, digital infrastructure, and social infrastructure sectors that provide essential services with downside protection, high barriers to entry and visible, recurring revenue generation. We seek to provide capital solutions that are flexible across the capital structure while generating cash yield through majority senior secured credit investments.

Stonepeak is headquartered in New York with offices in Houston, Washington, D.C., London, Hong Kong, Seoul, Singapore, Sydney, Tokyo, Abu Dhabi, and Riyadh. For more information, please visit www.stonepeak.com.

About OHA
Oak Hill Advisors (OHA) is a leading global credit-focused alternative asset manager with over 30 years of investment experience. OHA works with institutions and individuals and seeks to deliver a consistent track record of attractive risk-adjusted returns. The firm manages approximately $108 billion of capital across credit strategies, including private credit, high yield bonds, leveraged loans, stressed and distressed debt and collateralized loan obligations as of September 30, 2025. OHA’s emphasis on long-term partnerships with companies, sponsors and other partners provides access to a proprietary opportunity set, allowing for customized credit solutions across market cycles.
With over 400 experienced professionals across six global offices, OHA brings a collaborative approach to offering investors a single platform to meet their diverse credit needs. OHA is the private markets platform of T. Rowe Price Group, Inc. (NASDAQ – GS: TROW). For more information, please visit www.oakhilladvisors.com.

Omni Fiber Media Contact:
Andres Tovar
[email protected]
513-480-9610

SOURCE Omni Fiber

COSTA MESA, Calif., Dec. 1, 2025 — CerraCap Ventures and Impact Venture Capital today announced their merger to form CerraCap Impact Venture Capital (CIVC), creating one of the most globally connected venture platforms in the industry. The combined firm brings together an unmatched network of corporate customers, corporate investors, and strategic acquirers—positioning CIVC as a first-of-its-kind partner for founders needing rapid commercial validation and scalable enterprise adoption.

CIVC integrates CerraCap’s Sales & Scale™ commercialization engine with Impact Venture Capital’s Corporate Intelligence Platform™, a deep corporate development and investment network, spanning Fortune 500 companies and global strategic investors. Together, the platform gives startups accelerated access to enterprise customers, co-investors, corporate venture groups, and potential acquirers—shortening the path from early-stage innovation to revenue and ultimately to exit.

Operating at the intersection of enterprise AI, cybersecurity, digital health, national security, and advanced computing, CIVC will support founders building mission-critical technologies in sectors where commercial traction often depends on complex buyer landscapes. The firm’s combined global footprint across North America, Europe, India, and emerging markets enables founders to access international customer and investor networks far earlier in their journey.

CIVC’s leadership emphasized that the merger formalizes a long-standing collaborative relationship built on aligned values and complementary strengths.

Saurabh Ranjan, Co-Founder & Managing Partner, CerraCap Ventures, said:
“This merger creates a global institution built to deliver predictable, repeatable commercial outcomes for founders and investors.”

Saurabh Suri, Co-Founder & Managing Partner, CerraCap Ventures, added:
“Our cultural alignment and shared belief in value-creation beyond capital made this the natural next step.”

Eric Ball, Founding General Partner, Impact Venture Capital, noted:
“CIVC reflects the future of venture capital—global, integrated, and institutionally mature.”

Jack Crawford, Founding General Partner, Impact Venture Capital, stated:
“By unifying our platforms, we’re giving startups unparalleled access to corporate customers, investors, and strategic acquirers. Our goal is simple: shorten the time between innovation, adoption, and successful exit.”

CIVC and its partners are actively involved with the National Venture Capital Association’s CVC programs and serve as leaders in the Kauffman Fellows Corporate Venture Capital Special Interest Group, reinforcing the firm’s commitment to elevating corporate–startup collaboration across the global innovation ecosystem.

CerraCap Impact Venture Capital will continue building partnerships that connect founders directly to the enterprises and governments shaping the next decade of innovation.

More information is available at https://cerracapimpact.vc.

Contact: Nikki Arora, [email protected]

SOURCE CerraCap Ventures

LAVAL, QC, Dec. 1, 2025 – Morphocell Technologies Inc., a biotechnology company pioneering next-generation tissue therapeutics for organ replacement, today announced the completion of its US$50 million Series A financing following a US$10 million add-on led by Investissement Québec, the province’s leading economic development corporation, and CDP Venture Capital, part of Italy’s Cassa Depositi e Prestiti (CDP) group.

This financing extension builds upon the US$40 million Series A round closed in February 2024, which was led by Genson Capital, and marks an important milestone in Morphocell’s journey to transform the treatment of liver disease. The participation of two major institutional investors, both with long-term, mission-driven mandates, further strengthens the company’s foundation for growth, extending its operational runway to over three years.

“Since our initial Series A close, Morphocell has delivered remarkable progress across development, manufacturing and team expansion. The decision by Investissement Québec to deepen its commitment and by CDP Venture Capital to join our syndicate represents a powerful vote of confidence in our vision and execution. Their support further validates the global impact potential of our tissue-engineered therapies and strengthens our capacity to create transformative solutions to patients living with liver disease,” said Dr. Massimiliano Paganelli, CEO and co-founder of Morphocell Technologies.

Following the initial Series A close, Morphocell has grown to a team of 44 employees across its headquarters in the Greater Montréal Area and offices in Cambridge (Boston) and Toronto. The company’s vertically integrated operations span discovery, cell manufacturing, and preclinical development, reflecting its commitment to excellence in the regenerative medicine space.

A Strengthened Global Investor Syndicate

“Building on the first support from Impulsion PME in 2024, we are proud to continue our business relationship with Morphocell by reinvesting in its development through the new Fonds Impulsion and our own funds,” said Bicha Ngo, President and CEO of Investissement Québec. “The growing life-sciences industry is providing a global showcase for Québec talent and expertise and paving the way for the emergence of innovative solutions to multiple health challenges. Investissement Québec is delighted to help Morphocell achieve its ambitions.”

“We are particularly proud to be part of Morphocell’s journey, as it is a great example of how Italian world-class talent can innovate and drive impact on a global level.” said Alessandro Scortecci, Chief Direct Investments of CDP Venture Capital. “This marks our first investment in a Canadian biotech, a decision driven by our commitment to connect Italy with global innovation ecosystems. Our investment enables the establishment of Morphocell’s first European subsidiary, in Italy, which will build on the Country’s great talent, research capabilities, and industrial excellence, to strengthen the company’s global role in regenerative medicine.”

A Platform for the Future

With its Series A round now complete at US$50 million, Morphocell Technologies stands among the most well-funded private regenerative medicine companies in Canada. The financing strengthens Morphocell’s ability to:

• Advance its lead program, ReLiver^®, toward clinical proof-of-concept;
• Expand its manufacturing capacity and team of world-leading experts;
• Deepen its global collaborations and lay the foundation for future financing rounds.

Building on its strong presence in Québec and North America, Morphocell will now establish its first European subsidiary in Italy, a move that reflects the company’s Italian-founded roots and its commitment to contributing to Italy’s dynamic biotechnology sector. This expansion will serve as a strategic entry point into Europe, enabling Morphocell to build partnerships, access world-class talent and research infrastructure, and reinforce its position as a global leader in regenerative medicine.

“Morphocell’s goal has always been clear, to create revolutionary cell-based organ replacement therapies that cure patients,” added Dr. Paganelli. “This additional funding reinforces our shared conviction, with our investors, our partners, and our team, that we are building the future of regenerative medicine right here in Québec.”

“Our government is proud to support Morphocell Technologies in its growth. We want to help stimulate innovation in Quebec, which will play a decisive role in the evolution of modern medicine, particularly in regenerative medicine. This commitment is part of our desire to build a solid, dynamic, and forward-looking ecosystem where our companies can develop promising solutions for the health of tomorrow,” said Christine Fréchette, Minister of Economy, Innovation, and Energy.

About Morphocell Technologies

Morphocell Technologies is a Montreal-based regenerative medicine company developing stem cell–derived tissue and organ replacement therapies. Its proprietary iPSC-derived platform supports a broad pipeline of tissue-engineered solutions targeting severe organ dysfunctions, with liver disease as its first focus. Founded in 2018, Morphocell combines scientific excellence, clinical expertise, and cutting-edge manufacturing to bring next-generation regenerative therapies to patients worldwide.

To download images related to Morphocell, click here.

For more information, visit www.morphocell.com.

SOURCE Morphocell Technologies

• Financing led by Novartis Venture Fund and Forbion, with new investment from Omega Funds, Droia Ventures, YK Bioventures, and Digitalis Ventures
• Renewed backing from Vida Ventures, MPM BioImpact, Lightspeed Venture Partners, and Scripps Research

SAN DIEGO, Dec. 1, 2025 — Protego Biopharma, Inc., a clinical-stage biotechnology company dedicated to pioneering first-in-class small molecule therapeutics that reprogram protein folding to address systemic amyloid diseases and other protein misfolding disorders, today announced the completion of an oversubscribed $130 million Series B financing.

The round was led by Novartis Venture Fund and Forbion, with participation from new investors including Omega Funds, Droia Ventures, YK Bioventures, and Digitalis Ventures. Existing investors, including Vida Ventures, MPM BioImpact, Lightspeed Venture Partners, and Scripps Research, also participated, underscoring their continued conviction in the Protego approach. The round also reflects the active engagement of Ed Hurwitz, Executive Chairman, alongside Chris Weyrer, M.D., Ph.D., Principal at Vida Ventures and Acting Chief Business Officer of Protego, as the company advances its lead program.

Proceeds will advance Protego’s lead candidate, PROT-001, into a pivotal clinical trial for AL amyloidosis, a rare and often fatal condition caused by protein misfolding that leads to organ damage, especially in the heart.

“We are deeply grateful for the steadfast support of our existing investors, who have believed in us through every stage, and we are pleased to welcome leading global investors to join us on this journey. Their confidence underscores the promise of our science and the urgency of our mission,” said Brent Warner, Chief Executive Officer of Protego Biopharma. “With the capital raised, we are positioned to advance PROT-001 into pivotal trials, moving closer to delivering the first disease-modifying therapy for AL amyloidosis and offering new hope to patients who currently face devastating outcomes.”

Protego’s therapeutic strategy is rooted in human genetics and a unique pharmacological chaperone mechanism. These small molecules act as cellular “guides,” ensuring proteins fold correctly. By stabilizing immunoglobulin light chains and preventing amyloid buildup, PROT-001 addresses disease at its root cause rather than simply managing symptoms. This approach represents a potential paradigm shift not only for AL amyloidosis, but also for a wide spectrum of protein misfolding disorders with profound unmet needs.

“Protego is advancing a highly differentiated approach with the potential to transform treatment for patients with AL amyloidosis,” said Tim Lohoff, PhD, Principal at Forbion. “By targeting the root cause of this severe disease, PROT-001 has the potential to deliver the first truly disease-modifying therapy in this indication. At Forbion, we invest in bold teams turning breakthrough science into tangible medical and commercial impact, and Protego exemplifies that vision.”

About Protego Biopharma
Protego Biopharma is a San Diego-based biotech company focused on developing small-molecule drugs that target protein misfolding pathways. By reprogramming cellular processes to restore proper protein function, Protego aims to treat rare and systemic diseases with precision and improved patient outcomes. For more information, visit www.protegobio.com.

SOURCE Protego Biopharma

SHANGHAI, Nov. 29, 2025 — On the afternoon of November 26, a major Grade 5 fire spread across multiple residential buildings in Wang Fuk Court in Tai Po, Hong Kong, causing severe casualties and drawing widespread public concern. In response, on November 28, Qiming Venture Partners made a donation of HK$3 million to the Tai Po Wang Fuk Court Aid Fund established by the Hong Kong SAR Government, to support affected residents and contribute to post-disaster reconstruction.

The Hong Kong SAR Government established the Tai Po Wang Fuk Court Aid Fund on November 27, with an initial allocation of HK$300 million, to coordinate social resources and fully carry out rescue and recovery support. The fund is also open to donations from the public, aiming to unite support from all walks of life to facilitate efficient aid distribution. Qiming Venture Partners responded promptly with this donation, to assist those affected while fulfilling its corporate social responsibility.

Qiming Venture Partners expresses our condolences to the families impacted by the major fire, and our deepest respect to the firefighters and rescue personnel at the frontline. We are grateful for their exceptional professionalism and selfless dedication which were evident throughout the crisis. Qiming hopes that its contribution will help alleviate the challenges faced by affected residents and support their swift return to normal life. Qiming also calls on more social forces to join in the relief efforts and contribute to the rebuilding of the affected communities.

About Qiming Venture Partners

Qiming Venture Partners was founded in 2006. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Healthcare industries at the early and growth stages.

Since our debut, we have backed over 580 fast-growing and innovative companies. Over 210 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 80 portfolio companies that have achieved unicorn or super unicorn status.

Many of our portfolio companies are today’s most influential firms in their respective sectors, including Xiaomi, Meituan, Bilibili, Zhihu, Roborock, HESAI, UBTech, WeRide, HyperStrong, Insta360, Unisound, Gan & Lee Pharmaceuticals, Tigermed, Zai Lab, CanSino Biologics, Schrödinger, APT Medical, Sanyou Medical, AmoyDx, SinocellTech, AusperBio, Yuanxin Technology, Insilico Medicine, Medilink Therapeutics, LaNova Medicines, zai, StepFun, among many others.

SOURCE Qiming Venture Partners

SINGAPORE, Nov. 27, 2025 — RockFlow, a Singapore-based AI-native fintech company backed by Lanchi Ventures, recently announced it has raised tens of millions of U.S. dollars in a new financing round. The round was led by a top-tier global digital financial services platform, with continued participation from Lanchi Ventures, Monolith Management, Forwest Capital, and Evergreen.

The fresh capital will be used to advance RockFlow’s proprietary financial AI, “Bobby,” and to accelerate the company’s global business expansion.

The financing follows the success of the RockAlpha AI Stock Trading Arena, a live-stock market stress test that benchmarked LLMs against real-world volatility. The initiative validated that RockFlow’s AI agent, Bobby, can autonomously execute complex trading strategies, marking a pivotal shift from passive AI assistance to active, agentic decision-making.

Underpinning this growth is a strong regulatory foundation. RockFlow’s parent group recently secured Type 1 (Dealing in Securities), Type 4 (Advising on Securities), and Type 9 (Asset Management) licenses from the Hong Kong Securities and Futures Commission (SFC).This milestone cements the platform’s ability to conduct regulated financial business in the international financial hub. Building on this regulatory milestone, RockFlow is poised to scale its business operations worldwide.

The company plans to extend its service offerings into new verticals, including brokerage, trusts, stablecoins, and digital banking. This supports RockFlow’s goal to build a comprehensive “All-in-One” platform that integrates traditional equities with emerging asset classes such as crypto, Real World Assets (RWA), and private equity.

“AI Agents are fundamentally reshaping the entry point and user experience for financial services,” said Vakee, Founder & CEO of RockFlow. “Our mission is to make investing simple, smart and fun. We are building an interface where complex, professional financial services become accessible and personalized through AI, all while adhering to strict global compliance standards.”

Lanchi Ventures commented: “We invest in AI that brings professional depth to mass markets. RockFlow’s ‘All-in-One’ platform and Bobby AI perfectly embody this vision. We remain bullish on their expertise at the intersection of finance and AI Agents as they scale globally.”

About RockFlow

RockFlow is a Singapore-headquartered AI fintech company dedicated to bringing a simple, fun, and intelligent investment experience to global investors through AI innovation. Since its inception, the company has received multiple rounds of investment from top-tier global USD funds and prominent tech founders, serving users in over 40 countries and regions.

RockFlow (https://rockflow.ai/) supports trading in US and HK stocks, and offers innovative features such as “Auto-DIP,” simplified options, and copy-trading. In 2025, the company officially launched Bobby, the world’s first financial AI Agent. Built on a proprietary AI Agents architecture and financial large models, Bobby allows users to interact via natural language to complete the full investment loop—from opportunity spotting and analysis to strategy construction and execution—making investing accessible and engaging for everyone.

SOURCE Lanchi Ventures

MADRID, 27. November 2025 — Anyformat, eine generative KI-Plattform, die sich auf die Extraktion und Strukturierung komplexer Daten aus jeglichen Dokumenten spezialisiert hat, hat in einer von Kibo Ventures angeführten Seed-Runde 3,3 Millionen Euro eingeworben, an der sich auch 4Founders, Abac Nest Ventures und Decelera Ventures beteiligt haben. Alle drei Fonds haben auch in die vorherige Finanzierungsrunde des Unternehmens investiert.

Das Unternehmen entwickelt die nächste Generation der Dokumenteninfrastruktur, basierend auf generativer KI. Die Technologie ermöglicht es großen Unternehmen, Verträge, Rechnungen, E-Mails oder Präsentationen mit menschlicher Genauigkeit und maschineller Geschwindigkeit zu verarbeiten und dabei die vollständige Kontrolle über sensible Daten zu behalten. Anyformat hat bereits Projekte für die Regierung von Singapur, die L’Oréal Group und die IAG Group entwickelt und damit seine Fähigkeit unter Beweis gestellt, in komplexen Umgebungen mit hohen Anforderungen zu agieren.

Seit der Beschaffung von 520.000 Euro im Juni 2025 hat Anyformat seine Fähigkeiten über die herkömmliche Dokumentenextraktion hinaus erheblich erweitert. Das Unternehmen ist nun der einzige Anbieter, der aus einem Dokument extrahierte Informationen in Echtzeit mit den firmeneigenen Daten eines Unternehmens kombinieren kann. Dies ermöglicht die automatisierte Analyse unstrukturierter Dokumente bei gleichzeitigem Abgleich der Daten mit internen Aufzeichnungen wie Kundendatenbanken, Richtlinien, Produktkatalogen oder historischen Informationen.

Für Unternehmen, die mit komplexer Dokumentation und fragmentierten Systemen arbeiten, eliminiert diese Funktion manuelle Validierungsschritte, reduziert Fehler und beschleunigt wichtige Geschäftsprozesse. Laut dem Innovation Catalyst-Bericht von Dell Technologies sind 68 % der spanischen Unternehmen nicht in der Lage, ihre Daten in wertvolle Echtzeit-Erkenntnisse umzuwandeln – eine Lücke, die Anyformat schließen möchte.

„Der Markt für Dokumentenintelligenz tritt in eine neue Phase ein, die von generativer KI und agentenbasierten Systemen vorangetrieben wird. Anyformat hat eine einzigartige Technologie entwickelt, die es Unternehmen ermöglicht, kritische Prozesse zu automatisieren und gleichzeitig die Datenhoheit zu wahren, eine wesentliche Anforderung in Europa. Die Vision und das Talent der Gründer in Verbindung mit dem enormen Potenzial der KI in einem großen und wachsenden Markt waren ausschlaggebende Faktoren für unsere Investitionsentscheidung”, erklärt Javier Torremocha, Mitbegründer und geschäftsführender Partner bei Kibo Ventures.

Das Unternehmen arbeitet kontinuierlich an der Weiterentwicklung seiner Technologie, um jegliche Dateien in strukturierte Daten für Analysen, Business Intelligence und operative Arbeitsabläufe umzuwandeln, wobei stets strenge Datenschutz- und Sicherheitsstandards eingehalten werden.

Das Wachstum schreitet voran: Für das Jahr 2026 wird ein wiederkehrender Jahresumsatz von über 1 Million Euro prognostiziert

Anyformat prognostiziert für 2026 einen jährlichen wiederkehrenden Umsatz von über 1 Million Euro, angetrieben durch die Expansion in Europa und die steigende Nachfrage nach Automatisierung, Compliance-Tools und fortschrittlicher Dokumentenverarbeitung.

„Dokumente bilden das Rückgrat jeder Organisation. Unser Ziel ist es, Unternehmen dabei zu unterstützen, diese mit menschlicher Intelligenz, maschineller Geschwindigkeit und dem von modernen Vorschriften geforderten Sicherheitsniveau zu analysieren”, erklärt Juan Huguet, Geschäftsführer und Mitbegründer. Technischer Leiter und Mitbegründer Diego Pérez ergänzt: „Wir entwickeln Technologien, die weit über die einfache Digitalisierung von Dokumenten hinausgehen.”

Die neue Finanzierungsrunde wird die Produktentwicklung beschleunigen und die Ingenieurs- und Produktteams erweitern, wodurch die fortschrittlichen Extraktionsfähigkeiten und proprietären Fehlererkennungsmodelle gestärkt werden. Das Unternehmen wird außerdem ein spezielles Vertriebsteam aufbauen, das sich auf Spanien und die Europäische Union konzentriert.

Anyformat wird weiterhin in seine datenschutzorientierte Infrastruktur investieren und auf Zertifizierungen wie ISO 27001 hinarbeiten, die für die Betreuung großer Unternehmen und öffentlicher Einrichtungen unerlässlich sind.

MADRID, 27 novembre 2025 — Anyformat, une plateforme d’IA générative spécialisée dans l’extraction et la structuration de données complexes à partir de n’importe quel document, a levé 3,3 millions d’euros de fonds d’amorçage dans le cadre d’un tour de table dirigé par Kibo Ventures, avec la participation de 4Founders, Abac Nest Ventures et Decelera Ventures. Ces trois fonds ont également investi dans le précédent tour de financement de la société.

La société Anyformat construit la prochaine génération d’infrastructure documentaire alimentée par l’IA générative. Sa technologie permet aux grandes entreprises de traiter des contrats, des factures, des courriers électroniques ou des présentations avec une précision de niveau humain mais à la vitesse d’une machine, tout en conservant un contrôle total sur les données sensibles. Anyformat a déjà mis sur pied des projets pour le gouvernement de Singapour, le groupe L’Oréal et le groupe IAG, qui démontrent son aptitude à opérer dans des environnements complexes et très exigeants.

Depuis sa levée de fonds de 520 000 euros en juin 2025, Anyformat a considérablement élargi ses capacités au-delà de l’extraction traditionnelle de documents. C’est aujourd’hui le seul fournisseur qui soit en mesure de combiner en temps réel les informations extraites d’un document avec les données exclusives d’une entreprise. Cela favorise l’analyse automatisée des documents non structurés, ainsi que le recoupement des données avec des dossiers internes tels que les bases de données de clients, les politiques, les catalogues de produits ou les informations sur l’historique.

Pour les entreprises qui ont à gérer une documentation complexe et des systèmes fragmentés, cette capacité supprime les étapes de validation manuelle, réduit les erreurs et accélère les processus opérationnels décisifs. Selon le rapport de Dell Technologies sur les catalyseurs de l’innovation, 68 % des entreprises espagnoles sont incapables de transformer leurs données en informations profitables en temps réel : c’est cette lacune qu’Anyformat entend combler.

« Le marché de l’intelligence documentaire entre dans une nouvelle phase, portée par l’IA générative et les systèmes agentiques. Anyformat a mis au point une technologie unique qui aide les entreprises à automatiser les processus cruciaux tout en préservant la souveraineté des données, une exigence primordiale en Europe. La vision et le talent des fondateurs, associés au vaste potentiel de l’IA sur un marché important et en pleine croissance, ont été des facteurs clés dans notre décision d’investir », déclare Javier Torremocha, cofondateur et associé directeur de Kibo Ventures.

L’entreprise continue d’affiner sa technologie pour convertir n’importe quel fichier en données structurées au bénéfice de l’analyse, de la veille économique et des flux de travail opérationnels, toujours dans le respect de normes strictes en matière de confidentialité et de sécurité.

Sur la voie de la croissance : plus d’un million d’euros de revenu récurrent annuel prévu en 2026

Anyformat prévoit de dépasser le million d’euros de revenu récurrent annuel en 2026, grâce à son expansion européenne et à la demande croissante relative à l’automatisation, aux outils de conformité et au traitement avancé des documents.

« Les documents sont l’épine dorsale de toute organisation. Notre objectif est d’aider les entreprises à les analyser avec l’intelligence humaine, la rapidité de la machine et le niveau de sécurité requis par les réglementations modernes », commente Juan Huguet, directeur général et cofondateur. Diego Pérez, directeur technique et cofondateur, ajoute : « Nous construisons une technologie qui va bien au-delà de la simple numérisation de documents. »

Le nouveau financement accélérera le développement des produits et facilitera la croissance des équipes chargées de l’ingénierie et des produits, en renforçant les capacités d’extraction avancées et les modèles de détection d’erreurs exclusifs. L’entreprise mettra par ailleurs en place une équipe de vente dédiée à l’Espagne et à l’Union européenne.

Anyformat continuera d’investir dans son infrastructure axée sur la protection de la vie privée et s’efforcera d’obtenir des certifications telles que la norme ISO 27001, essentielle pour répondre aux besoins des grandes entreprises et des institutions publiques.

Funding extension led by European technology investor Hi Inov with participation from existing investors UVC Partners and Capnamic Ventures

MUNICH, Nov. 27, 2025 — Rencore today announced it has extended its Series A funding to a total of USD 15 million. The extension round was led by European technology investor Hi Inov, with continued participation from existing investors UVC Partners and Capnamic  Ventures. The additional capital will accelerate Rencore’s international expansion in Europe and North America and further strengthen its position as a leader in AI and Agent Governance for enterprise Microsoft 365 environments.

Rencore provides a cloud-based governance platform that enables large organizations to manage collaboration, security, compliance, and automation across Microsoft 365, the Power Platform, and AI-driven services such as Copilot and enterprise agents. The solution gives IT and compliance teams deep visibility into their environments, allows them to enforce policies, reduce risk, and automate remediation across collaboration and AI data sources.

Building on its established success in Microsoft 365 governance, Rencore has extended its platform to include advanced capabilities for AI and Agent Governance. This enables enterprises to control how AI systems interact with business data, ensure responsible AI use, and align with new standards for trust, risk, and security. With the growing adoption of AI in large organizations, these capabilities are becoming essential for CIOs and IT leaders managing Copilot deployments and other AI integrations at scale.

The Rencore AI and Agent Governance solution is already used by leading enterprises to identify and manage AI agents and Copilot integrations across their Microsoft environments. Customers use Rencore to detect and mitigate data exposure risks, enforce security and compliance policies, and ensure that AI systems operate within organizational and regulatory boundaries.

Rencore serves some of the world’s largest enterprises, including Amgen, Honeywell, Lufthansa Group, and Siemens Healthineers, helping them to secure collaboration environments, improve operational efficiency, and prepare their data estates for safe AI adoption.

“AI adoption across the enterprise is creating a new layer of complexity in governance, security, and compliance,” said Julius Jürging, Partner at Hi Inov. “Rencore is uniquely positioned to solve these challenges by extending its proven Microsoft 365 governance foundation into AI and Agent Governance. We are convinced that Rencore will play a defining role in how enterprises establish control and trust in the age of AI.“

“Enterprises today need to govern not only their data but also the AI systems that use it,” said Matthias Einig, CEO of Rencore. “This investment allows us to accelerate our mission of helping organizations adopt AI responsibly and securely, while scaling our presence in Europe and North America. The demand for AI governance is growing fast, and Rencore is ready to lead this next stage of enterprise transformation.“

Rencore will use the new funding to expand its AI and Agent Governance capabilities, grow its product and engineering teams, and scale its go-to-market operations in Europe and North America. The company will continue to work closely with enterprises, system integrators, and managed service providers to help them implement sustainable governance frameworks for collaboration and AI. This next phase of growth focuses on enabling customers to innovate securely, maintaining full control and compliance while adopting AI at scale.

About Rencore

Rencore is a Munich-based software company specializing in governance, security, and compliance solutions for Microsoft 365, the Power Platform, and enterprise AI. Its cloud platform enables organizations to inventory, analyze, and control collaboration and automation environments at scale. Rencore’s customers include global enterprises and public sector organizations that rely on its technology to maintain security, ensure compliance, and govern AI responsibly across the modern workplace.

Website: rencore.com

About Hi Inov

Hi Inov is a European B2B venture capital fund founded by entrepreneurs for entrepreneurs, with offices in Paris, Lyon, and Munich. Hi Inov supports high-growth European companies from Seed to Series A and B, focusing on driving transformation in the industrial and service sectors through innovative technological solutions. With a highly experienced team, a strong German-French foundation, and an extensive network, Hi Inov provides strategic guidance to help companies scale from early-stage ventures to global category leaders. Backed by over €350 million in capital from entrepreneurs, mid-sized and large corporations, and institutional investors, Hi Inov integrates sustainability and energy efficiency into its investment strategy and portfolio support. Hi Inov’s European portfolio includes market leaders such as Deepki, Platform.sh, 360 Learning, Agorapulse, Customers for Trade, awork, and Ninox.

Website: www.hiinov.com

About UVC Partners

UVC Partners is a leading venture capital firm investing in European B2B tech startups, with offices in Munich and Berlin. Managing over €600 million in assets, UVC Partners typically invests between €1 million and €10 million initially, with up to €30 million per startup, focusing on DeepTech, ClimateTech, Mobility, and Software/AI. As an independent partner of UnternehmerTUM—Europe’s leading startup ecosystem—UVC Partners has unique access to proprietary deal flow, over 1,000 corporates and SMEs, and top talent from the Technical University of Munich, one of Europe’s leading technical universities. UVC Partners’ portfolio includes Flix, Isar Aerospace, planqc, Proxima Fusion, Reverion, Tacto, TWAICE, DeepDrive, STABL, and many more. All portfolio companies and founders benefit from the team’s extensive investment and exit experience, its ability to build sustainable industry leaders, and the UnternehmerTUM network—particularly when it comes to accelerating market entry.

Website: www.uvcpartners.com

About Capnamic

Capnamic is a leading European early-stage venture capital firm with offices in Cologne, Munich, and Berlin. The VC invests in outstanding teams from the German-speaking region – from pre-seed to Series A. All portfolio companies benefit from Capnamic’s unique network of global investors and industry partners, as well as hands-on support, mentoring, and knowledge sharing. The Capnamic team brings extensive expertise, including over 100 investments, numerous successful exits and IPOs, and a strong entrepreneurial track record within the investment team. The General Partners are Christian Siegele, Christian Knott, Jörg Binnenbrücker, and Olaf Jacobi.

Website: capnamic.com

SOURCE Rencore GmbH